Medicalgorithmics, a WSE-listed developer of an innovative platform and AI algorithms for ECG analysis, has signed an agreement with its first South American partner, Sharp Tech, a leading Peruvian distributor of medical software and equipment. The agreement covers the distribution of DRP software, DRAI algorithms, as well as Kardiobeat.ai and Pocket ECG devices in Peru. The signing of the contract with the Peruvian distributor is the result of many months of promotional and marketing work in the LATAM region, including participation in sector conferences
– This is the second agreement we have signed this year. It is significant in that it opens up a completely new, very large market for cardiology services. For several months now, our specialists have been actively promoting our services in LATAM, including recently at important sector events in Buenos Aires and Santiago de Chile. Signing the agreement with the Peruvian distributor allows us to offer our services and devices in Peru, which provides a basis for further expansion in this region. There is a lot to fight for. The South American ECG services market is valued at nearly USD 2.5 billion, and in many countries in the region, telemedicine services are becoming increasingly popular, thanks in part to government investments. This is the perfect moment for our company – comments Dr. Kris Siemionow, CEO of Medicalgorithmics.
Sharp Technologies is a leading Peruvian distributor of AI-powered technology solutions for remote patient monitoring, diagnostics, and telemedicine. The solutions offered by the company meet the highest quality standards. The services available to the new partner’s customers include, among others, modern devices for remote heart monitoring and tracking of vital signs.
The agreement with Sharp Tech is the second agreement concluded in 2026. In early January, the ECG industry innovator established cooperation with the American IDTF – CardioDiagnostics, which specializes in solutions for cardiac care with an emphasis on heart monitoring and remote diagnostics through cloud software and devices for clinical electrocardiographic monitoring. Under the agreement, the Company will provide its partner with innovative AI algorithms for ECG analysis – Deep Rythm AI (DRAI).
The entire year 2025 was a record-breaking one for Medicalgorithmics. Listed on the Warsaw Stock Exchange, the medtech company grew rapidly, acquiring new customers and activating existing ones – it signed a record 20 contracts (more than in 2024: 14), which translated into a significant increase in its share price (+85% in 2025). The fourth quarter proved to be a breakthrough. During this period, the company recorded estimated consolidated sales revenues of PLN 10.2 million, which represents an increase of +74% y/y and +42% q/q. At the same time, the company recorded a positive estimated EBITDA of PLN 1.0 million. The above-average results recorded by the Company are the result of consistent scale building resulting from the effective transformation of the business model, which is based on the sale of ECG analysis software, as well as the development of R&D projects, led by the breakthrough VCAST technology.